{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:49:46Z","timestamp":1792658986936,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":6769,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1111\/j.1600-6143.2004.00454.x","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T11:03:34Z","timestamp":1084532614000},"page":"996-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":267,"title":["Rituximab as Treatment for Refractory Kidney Transplant Rejection"],"prefix":"10.1016","volume":"4","author":[{"given":"Yolanda T.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan N.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Pirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans W.","family":"Sollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2004.00454.x_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1980.75","article-title":"Role of humoral presensitization in human renal transplant rejection","volume":"17","author":"Gailiunas","year":"1980","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib2","first-page":"146","article-title":"The influence of presensitization on graft survival rate","volume":"81","author":"Salvieterra","year":"1977","journal-title":"Surgery"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00007890-200103150-00013","article-title":"Acute humoral rejection in renal allograft recipients: Incidence, serology and clinical characteristics","volume":"71","author":"Crespo","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1681\/ASN.V12suppl_1s48","article-title":"Steroid resistant kidney transplant rejection: diagnosis and treatment","volume":"12","author":"Bock","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib6","first-page":"7","article-title":"Future strategies toward the cure of indolent B-cell malignancies. New biologic therapies","volume":"36","author":"Rai","year":"1999","journal-title":"Seminars in Hematology"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib7","first-page":"9","article-title":"Rituximab: an insider's historical perspective","volume":"27","author":"Grillo-Lopez","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa035588","article-title":"Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling","volume":"349","author":"Sarwal","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00007890-200004271-00964","article-title":"Treatment of steroid resistant rejection with a novel anti B-cell preparation, Rituximab","volume":"69","author":"Becker","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00007890-199508000-00006","article-title":"Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients","volume":"60","author":"Reisater","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1034\/j.1600-6143.2003.00121.x","article-title":"Utility of intravenous immune globulin in kidney transplantation: Efficacy, safety, and cost implications","volume":"3","author":"Jordan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/eji.1830160802","article-title":"Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes","volume":"16","author":"Tedder","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib15","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood.V84.8.2457.2457","article-title":"Phase I clinical trial using escalating single dose infusion of chimeric anti-CD 20 monoclonal antibody in patients with recurrent B-cell lymphoma","volume":"84","author":"Maloney","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib16","first-page":"1927","article-title":"Rituximab for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib18","first-page":"637a","article-title":"The anti-tumor effect of monoclonal anti-CD20 antibody therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin's lymphoma cell lines","volume":"88","author":"Maloney","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1600-6143.2002.20801.x","article-title":"Management of the highly HLA-sensitized patient. A novel role for intravenous gammaglobulin","volume":"2","author":"Jordan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib21","first-page":"458","article-title":"Basiliximab and rituximab increase survival in pig-to-baboon kidney xenotransplantation","volume":"1","author":"Becker","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(99)02058-9","article-title":"Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation","volume":"354","author":"Cook","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02787213","article-title":"Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder","volume":"15","author":"Tsai","year":"1998","journal-title":"Med Oncol"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib24","first-page":"99","article-title":"A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia","volume":"27","author":"Saleh","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1600-6143.2004.00454.x_bib25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","article-title":"Rituximab in idiopathic membranous nephropathy: a one-year prospective study","volume":"14","author":"Ruggenenti","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2004.00454.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522075438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522075438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2004.00454.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:30:02Z","timestamp":1761625802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522075438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1600613522075438"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00454.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab as Treatment for Refractory Kidney Transplant Rejection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00454.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Journal of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}